Volume 92 Issue 12 | p. 9 | News of The Week
Issue Date: March 24, 2014

FDA Bans Another Indian Drug Plant

Generics: Quality problems plague Indian producers
Department: Business
Keywords: India, warning letters, cGMP, generic, pharmaceuticals, compliance, outsourcing

Continuing a crackdown against shoddy foreign drug manufacturing, the U.S. Food & Drug Administration has again banned imports of pharmaceuticals made at a facility in India.

The latest action targets a Sun Pharmaceutical Industries plant in Karkhadi, Gujarat, that produces the antibiotic cephalosporin. Sun is one of India’s largest drug producers.

According to Sun, FDA’s action took place after a recent inspection of the facility during which agency officials identified instances . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society